A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% ...

Custom-fitted oral appliances reduce airway obstruction by physically repositioning the lower jaw or tongue forward during sleep. While CPAP machines generally lower the apnea-hypopnea index more ...

Right-size your expectations.

Last week, Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition in which breathing stops and starts repeatedly during sleep. The ...

The US Food and Drug Administration (FDA) has approved the obesity treatment tirzepatide (Zepbound, Eli Lilly) for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. The ...

Women over 50 with sleep apnea rarely snore loudly or fit the textbook profile. Instead, they show up with anxiety, brain fog, and unexplained weight gain — and spend years being treated for the wrong ...